CARMUSTINE News

CARMUSTINE currently has 8 news articles, with 50 predicted indications.

This page combines the AI-predicted indications for CARMUSTINE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (50):
- gemistocytic astrocytoma (99.0%)
- oligoastrocytoma (99.0%)
- angiocentric glioma (99.0%)
- intravascular large B-cell lymphoma (99.0%)
- primary cutaneous diffuse large B-cell lymphoma, Leg type (99.0%)
- mantle cell lymphoma (99.0%)
- juvenile pilocytic astrocytoma (99.0%)
- T-cell/histiocyte rich large B cell lymphoma (99.0%)
- glioblastoma (disease) (99.0%)
- classic Hodgkin lymphoma (99.0%)
- chordoid glioma of the third ventricle (99.0%)
- diffuse large B-cell lymphoma (99.0%)
- plasma cell myeloma (99.0%)
- embryonal carcinoma of the central nervous system (99.0%)
- Hodgkins lymphoma (99.0%)
- non-Hodgkin lymphoma (99.0%)
- Langerhans cell histiocytosis (99.0%)
- astroblastoma (99.0%)
- pituicytoma (99.0%)
- fibrillary astrocytoma (99.0%)
- protoplasmic astrocytoma (99.0%)
- giant cell glioblastoma (99.0%)
- oligodendroglial tumor (99.0%)
- peripheral primitive neuroectodermal tumor (99.0%)
- pleomorphic xanthoastrocytoma (99.0%)
- anaplastic oligodendroglioma (99.0%)
- lymphoma (99.0%)
- anaplastic astrocytoma (99.0%)
- embryonal carcinoma (99.0%)
- obsolete Hodgkin's granuloma (99.0%)
- neuroepithelial neoplasm (99.0%)
- classic Hodgkin lymphoma, lymphocyte-rich type (99.0%)
- anaplastic ependymoma (99.0%)
- ALK-positive large B-cell lymphoma (99.0%)
- B-cell neoplasm (99.0%)
- Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly (99.0%)
- anaplastic oligoastrocytoma (99.0%)
- glioma (99.0%)
- gliosarcoma (99.0%)
- primary mediastinal large B-cell lymphoma (99.0%)
- Hodgkin's paragranuloma (99.0%)
- diffuse large B-cell lymphoma of the central nervous system (99.0%)
- ependymoblastoma (99.0%)
- primary central nervous system lymphoma (99.0%)
- brain glioblastoma (99.0%)
- pilomyxoid astrocytoma (99.0%)
- brain cancer (99.0%)
- malignant glioma (99.0%)
- diffuse astrocytoma (99.0%)
- lymphosarcoma (99.0%)